Perspective Therapeutics (CATX) Equity Ratio (2011 - 2026)
Perspective Therapeutics recorded quarterly Equity Ratio of 0.85 in Q1 2026, up 9.07% quarter-over-quarter from 0.78 in Q4 2025, and down 2.13% year-over-year from 0.86 in Q1 2025.
Perspective Therapeutics' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.85 for Q1 2026.
- In Q1 2026, Equity Ratio fell 2.13% year-over-year to 0.85; the TTM figure through Mar 2026 stood at 0.85 (down 2.13% YoY), while the FY2025 annual figure was 0.78, down 9.0% from the prior year.
- Equity Ratio came in at 0.85 for Q1 2026 at Perspective Therapeutics, up from 0.78 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2022 to a low of 0.77 in Q4 2023.
- A 5-year average of 0.87 and a median of 0.86 in 2025 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio decreased 18.35% in 2023 and rose 10.96% in 2024, its largest moves.
- Perspective Therapeutics' Equity Ratio stood at 0.94 in 2022, then declined by 18.35% to 0.77 in 2023, then increased by 10.96% to 0.85 in 2024, then declined by 9.0% to 0.78 in 2025, then increased by 9.07% to 0.85 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.85, 0.78, and 0.82 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.78 |
| Sep 30, 2025 | 0.82 |
| Jun 30, 2025 | 0.86 |
| Mar 31, 2025 | 0.86 |
| Dec 31, 2024 | 0.85 |
| Sep 30, 2024 | 0.84 |
| Jun 30, 2024 | 0.88 |
| Mar 31, 2024 | 0.83 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.89 |
| Jun 30, 2023 | 0.90 |
| Mar 31, 2023 | 0.92 |
| Dec 31, 2022 | 0.94 |
| Sep 30, 2022 | 0.92 |
| Jun 30, 2022 | 0.95 |
| Mar 31, 2022 | 0.96 |
| Dec 31, 2021 | 0.96 |
| Sep 30, 2021 | 0.96 |
| Jun 30, 2021 | 0.96 |
| Mar 31, 2021 | 0.96 |
| Dec 31, 2020 | 0.82 |
| Sep 30, 2020 | 0.63 |
| Jun 30, 2020 | 0.66 |
| Mar 31, 2020 | 0.65 |
| Dec 31, 2019 | 0.69 |
| Sep 30, 2019 | 0.69 |
| Jun 30, 2019 | 0.82 |
| Mar 31, 2019 | 0.81 |
| Dec 31, 2018 | 0.81 |
| Sep 30, 2018 | 0.83 |
| Jun 30, 2018 | 0.67 |
| Mar 31, 2018 | 0.80 |
| Dec 31, 2017 | 0.84 |
| Sep 30, 2017 | 0.85 |
| Jun 30, 2017 | 0.86 |
| Mar 31, 2017 | 0.88 |
| Dec 31, 2016 | 0.91 |
| Sep 30, 2016 | 0.90 |
| Jun 30, 2016 | 0.91 |
| Mar 31, 2016 | 0.89 |
| Dec 31, 2015 | 0.89 |
| Jun 30, 2015 | 0.90 |
| Jun 30, 2014 | 0.90 |
| Mar 31, 2014 | 0.91 |
| Dec 31, 2013 | 0.79 |
| Sep 30, 2013 | 0.79 |
| Jun 30, 2013 | 0.76 |
| Mar 31, 2013 | 0.80 |
| Dec 31, 2012 | 0.81 |
| Sep 30, 2012 | 0.84 |
| Jun 30, 2012 | 0.78 |
| Mar 31, 2012 | 0.81 |
| Dec 31, 2011 | 0.79 |
| Sep 30, 2011 | 0.77 |
| Jun 30, 2011 | 0.82 |